InvestorsHub Logo
Followers 2
Posts 871
Boards Moderated 0
Alias Born 09/15/2007

Re: nw_La post# 64255

Saturday, 05/26/2012 1:50:57 AM

Saturday, May 26, 2012 1:50:57 AM

Post# of 64738
The penny stock fraud and scams are...

littered with web sites that have pictures of people, of companies assigned patents, and of companies that issue press releases.

'Surely those scientists/researchers weren't in on a scam'

Let's go back to one of the very first 'scientists' hired and touted by the reconstituted Cytogenix named Jonathan Elliston...

http://google.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHtmlSection1?SectionID=1277613-78024-82407&SessionID=RvbuFvqOgVUSR_7

=================================================
Dr. Elliston, Ph.D., J.D., M.B.A., has served as the Company's Director of Strategic Planning and Intellectual Property since September 1, 1999 and as the Company's Vice President of Research and Development since April 11, 2000. He is in charge of managing and creating intellectual property and manages laboratory operations. He is also the primary contact for science and technology.

Dr. Elliston earned his PhD in Physiology at the University of Illinois, Champaign-Urbana in 1987. Subsequently he was a post-doctoral fellow of Dr. Bert O'Malley in the Department of Cell Biology at Baylor College of Medicine, Houston, Texas. His primary focus was genetically engineered activators of gene expression. Dr. Elliston remained at Baylor College of Medicine as an Assistant Professor in the Department of Pediatrics until 1997. During his academic career at the Texas Medical Center, he earned a MBA and JD at the University of Houston.
=================================================

What is he really ? A scientist ? Hardly...he is a penny stock patent lawyer and hustler..

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=79086




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.